<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Thu, 23 Apr 2026 06:45:03 -0400--><rss version="2.0">
    <channel>
        <title>Mustang Bio, Inc. (MBIO) Press Releases</title>
        <link>https://ir.mustangbio.com/news-events/press-releases/rss</link>
        <description></description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/mustangbio/files/theme/images/logo-sm.png</url>
                <title>Mustang Bio, Inc. Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.mustangbio.com/news-events/press-releases/detail/192/mustang-bio-granted-orphan-drug-designation-by-u-s-fda-for</link>
                <pubDate>Mon, 07 Jul 25 08:30:00 -0400</pubDate>
                <guid>https://ir.mustangbio.com/news-events/press-releases/detail/192/mustang-bio-granted-orphan-drug-designation-by-u-s-fda-for</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.mustangbio.com/news-events/press-releases/detail/191/mustang-bio-regains-compliance-with-nasdaq-capital-market</link>
                <pubDate>Wed, 05 Mar 25 16:15:00 -0500</pubDate>
                <guid>https://ir.mustangbio.com/news-events/press-releases/detail/191/mustang-bio-regains-compliance-with-nasdaq-capital-market</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Mustang Bio Announces Sale of Fixed Assets and Exit of Facility]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.mustangbio.com/news-events/press-releases/detail/190/mustang-bio-announces-sale-of-fixed-assets-and-exit-of</link>
                <pubDate>Thu, 27 Feb 25 16:05:00 -0500</pubDate>
                <guid>https://ir.mustangbio.com/news-events/press-releases/detail/190/mustang-bio-announces-sale-of-fixed-assets-and-exit-of</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.mustangbio.com/news-events/press-releases/detail/189/mustang-bio-regains-compliance-with-nasdaq-minimum-bid</link>
                <pubDate>Tue, 11 Feb 25 16:10:00 -0500</pubDate>
                <guid>https://ir.mustangbio.com/news-events/press-releases/detail/189/mustang-bio-regains-compliance-with-nasdaq-minimum-bid</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Mustang Bio Announces Closing of $8 Million Public Offering]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.mustangbio.com/news-events/press-releases/detail/188/mustang-bio-announces-closing-of-8-million-public-offering</link>
                <pubDate>Mon, 10 Feb 25 08:00:00 -0500</pubDate>
                <guid>https://ir.mustangbio.com/news-events/press-releases/detail/188/mustang-bio-announces-closing-of-8-million-public-offering</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Mustang Bio Announces Pricing of $8 Million Public Offering]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.mustangbio.com/news-events/press-releases/detail/187/mustang-bio-announces-pricing-of-8-million-public-offering</link>
                <pubDate>Thu, 06 Feb 25 07:00:00 -0500</pubDate>
                <guid>https://ir.mustangbio.com/news-events/press-releases/detail/187/mustang-bio-announces-pricing-of-8-million-public-offering</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Mustang Bio Announces Reverse Stock Split]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.mustangbio.com/news-events/press-releases/detail/186/mustang-bio-announces-reverse-stock-split</link>
                <pubDate>Tue, 14 Jan 25 08:00:00 -0500</pubDate>
                <guid>https://ir.mustangbio.com/news-events/press-releases/detail/186/mustang-bio-announces-reverse-stock-split</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Mustang Bio Receives Positive Listing Determination from Nasdaq]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.mustangbio.com/news-events/press-releases/detail/185/mustang-bio-receives-positive-listing-determination-from</link>
                <pubDate>Tue, 12 Nov 24 08:30:00 -0500</pubDate>
                <guid>https://ir.mustangbio.com/news-events/press-releases/detail/185/mustang-bio-receives-positive-listing-determination-from</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.mustangbio.com/news-events/press-releases/detail/184/mustang-bio-granted-orphan-drug-designation-by-u-s-fda-for</link>
                <pubDate>Thu, 07 Nov 24 08:30:00 -0500</pubDate>
                <guid>https://ir.mustangbio.com/news-events/press-releases/detail/184/mustang-bio-granted-orphan-drug-designation-by-u-s-fda-for</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.mustangbio.com/news-events/press-releases/detail/183/mustang-bio-announces-exercise-of-warrants-for-4-million</link>
                <pubDate>Thu, 24 Oct 24 14:10:00 -0400</pubDate>
                <guid>https://ir.mustangbio.com/news-events/press-releases/detail/183/mustang-bio-announces-exercise-of-warrants-for-4-million</guid>
                                                                            </item>
            </channel>
</rss>